Shining a light on small diseased tissues
13 November, 2017Singaporean researchers have created polymer nanoagents that can 'light up' tiny areas of diseased tissues that conventional methods fail to detect.
New ARC training centre dedicated to biopharmaceuticals
09 November, 2017The ARC Industrial Transformation Training Centre in Biopharmaceutical Innovation has been officially opened at The University of Queensland, 16 months after it was initially announced.
Researchers discover a missing piece of the drug design jigsaw
10 October, 2017UK researchers have discovered a new way of analysing how drugs interact with molecules in the body, which could lead to the development of better treatments with fewer side effects.
MTPConnect signs MoU with Medical Alley Association
05 October, 2017MTPConnect has signed a memorandum of understanding with the Medical Alley Association, a Minnesota-based organisation that enables health innovation and care organisations to successfully influence the evolution of health care.
Printed medication: the future of pharmaceuticals
03 October, 2017US scientists have developed technology that can print pure, ultraprecise doses of drugs onto a wide variety of surfaces, in a breakthrough that could one day enable on-site printing of custom-dosed medications at pharmacies, hospitals and other locations.
Diabetes drug found to have anti-ageing properties
18 September, 2017Australian researchers have discovered that metformin, a common anti-diabetic drug, could have anti-ageing properties which could lead to longer, healthier lifespans.
BioScience Managers invests in REX Bionics
12 September, 2017Australian life sciences investment firm BioScience Managers has chosen a robotic exercise assist device (REX) as its first investment for the Biomedical Translation Fund.
2017 Medical Devices Fund winners announced
11 September, 2017The NSW Government announced the winners of the Medical Devices Fund at a ceremony held at Parliament House.
Medtech entrepreneur Lusia Guthrie joins BioMelbourne Network board
08 September, 2017BioMelbourne Network has announced the appointment of Lusia Guthrie to its board of directors. With over 35 years in pharmaceutical and bioscience industries, Guthrie is an experienced executive and medtech entrepreneur, with strong leadership skills and international industry networks.
M2 facility to keep Australia's medtech industry healthy
05 September, 2017CSIRO, Monash University and the Monash Health Translation Precinct (MHTP) have announced the creation of M2 — a new facility that combines technology, research and medical science.
Boehringer Ingelheim initiates Phase IIa study of liver disease drug
25 August, 2017Boehringer Ingelheim has initiated a European and North American Phase IIa trial in non-alcoholic steatohepatitis (NASH) of investigational drug candidate BI 1467335, acquired from fellow pharma company Pharmaxis in May 2015.
Adherium sells its 100,000th Smartinhaler
17 August, 2017Digital health company Adherium is celebrating a significant milestone, having recently manufactured and sold its 100,000th Smartinhaler.
Treating childhood allergies with gut bacteria
16 August, 2017 by Lauren DavisAustralian biotech company Ondek is on a mission to develop an immunotherapy based on the gram-negative bacterium Helicobacter pylori, which it hopes to eventually deploy as a new treatment for childhood allergy.
Bendable batteries can be implanted in the body
11 August, 2017Chinese researchers have engineered bendable batteries, suitable for implantation in the human body, which can run on body-inspired liquids such as a normal IV saline solution and a cell-culture medium.
New regenerative tissue technology developed
08 August, 2017Scientists have developed a new technology, tissue nano-transfection (TNT), that can generate any cell type of interest for treatment within a patient's own body.
